CD44 induced enhancement of phosphatase activity and calcium influx: Modifications of EGR-1 expression and cell

Ronny R Racine1, Nathan A Manalo2, Jessica M F Hall1

  • 1Department of Cell Biology and Immunology, University of North Texas Health Science Center, 3500, Camp Bowie Boulevard, Fort Worth TX 76104, United States.

Insights

CD44 expression in Jurkat cells impairs cell proliferation by disrupting the cell cycle and reducing Akt phosphorylation. This is linked to increased phosphatase activity and altered calcium signaling, impacting EGR-1 expression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • CD44 is a cell surface glycoprotein involved in cell adhesion and migration.
  • Dysregulation of CD44 has been implicated in various cancers.
  • The precise mechanisms by which CD44 influences intracellular signaling pathways remain under investigation.

Purpose of the Study:

  • To elucidate how CD44 expression affects Akt phosphorylation, EGR-1 expression, and cell proliferation.
  • To investigate the role of calcium (Ca2+) in mediating these CD44-dependent effects.
  • To explore the involvement of phosphatase activity in the observed signaling alterations.

Main Methods:

  • Engineered E6.1 Jurkat cells to express CD44.
  • Utilized flow cytometry for cell cycle analysis.
  • Employed Western blotting to assess Akt phosphorylation and EGR-1 expression.
  • Measured phosphatase activity using a commercial kit.
  • Investigated calcium's role using Ca2+ chelation and Ni2+ treatment.
  • Quantified intracellular Ca2+ levels with fura-2 AM staining.

Main Results:

  • CD44-expressing cells exhibited cell cycle disruption at the G1 to S transition.
  • Ca2+ chelation impaired Akt phosphorylation and EGR-1 expression in both CD44+ and control cells.
  • Ni2+ treatment disrupted cell proliferation, suggesting calcium release-activated calcium channel (CRAC) involvement.
  • CD44-expressing cells showed significantly higher intracellular Ca2+ levels.
  • Non-calcium-mediated phosphatase activity was markedly greater in CD44-expressing cells.

Conclusions:

  • Enhanced phosphatase activity in CD44-expressing cells increases Akt dephosphorylation.
  • Elevated intracellular Ca2+ in CD44+ cells partially maintains Akt phosphorylation but at reduced levels.
  • Reduced Akt phosphorylation leads to decreased EGR-1 expression and consequently, impaired cell proliferation.
  • CD44 influences cell proliferation through modulation of calcium signaling and phosphatase activity, impacting key signaling proteins.

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.7K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
8.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K